Updated laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication
Bolded Key Takeaway: Letting tirzepatide sit at room temperature for 30 minutes does not spoil the medication

News provided by Designs for Health Jun 17, 2026, 10:17 ET New probiotic and postbiotic blend targets microbiome health, metabolic balance, and healthy body composition through clinically studied ingredients* PALM COAST, Fla., June 17, 2026 /PRNewswire/ -- Designs for Health, the practitioner-recommended and preferred brand for high-quality, research-backed supplements, today announced the launch of Akkermansia Pro GLP-1 Probiotic, a groundbreaking once-daily probiotic and postbiotic formula that combines live Akkermansia muciniphila with the clinically studied BPL1 postbiotic to support the gutmetabolic connection, the body's natural GLP-1 production, and healthy weight management.* As research continues to explore the connection between the gut microbiome and metabolic health, emerging science suggests that specific keystone bacterial strains, those that are foundational to the gut microbiome, may play a vital role in supporting appetite regulation, blood sugar metabolism, gut barrier integrity, and overall metabolic resilience
%20on%20a%20100%E2%80%91unit%E2%80%91per%E2%80%91mL%20syringe%3F)
Documentation can also help if access depends on a labeled metabolic indication
Disadvantage: long-term efficacy beyond 48 weeks still being studied in Phase 3 trials
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management